Wockhardt Widens Miqnaf Access as Q2 Revenue Rises 24%
Wockhardt Miqnaf access widens after DCGI lifted a supply condition on the novel antibiotic, as Q2 FY27 revenue rose 24% to ₹969 crore on biotech growth.
ANTIMICROBIAL-RESISTANCE
Agilus Diagnostics Showcases Microbira’s Under-Three-Minute AI Microbial ID to Scotland Delegation, Eyes AMR Collaboration
Agilus Diagnostics hosted Scotland Secretary Douglas Alexander at its Mumbai lab to demonstrate Edinburgh-based Microbira’s AI-driven microbial identification platform, which names pathogens in under three minutes after culture, as both sides explore collaboration on antimicrobial resistance.
AI-Driven Pharmacy Innovation: Transforming Access to Super Speciality Medicines
Something meaningful is shifting in how India’s most vulnerable patients access the medicines they need. For years, the super speciality […]
Effective solutions for tackling antimicrobial resistance
Antimicrobial Resistance (AMR) is a growing concern across the globe with the World Health Organization (WHO) also working with countries […]
National Action Plan finalised to combat antimicrobial resistance
Stressing on a coordinated effort to stop the spread of antimicrobial resistance (AMR), Minister of Health and Family Welfare JP […]
US & India jointly reiterate importance of holistic approaches & partnerships in healthcare
During the bilateral meeting between India and the United States (US) on June 6 in Washington, the US, a range […]
